147 related articles for article (PubMed ID: 23203087)
1. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis.
Calzolari F; Appolloni I; Tutucci E; Caviglia S; Terrile M; Corte G; Malatesta P
Neoplasia; 2008 Dec; 10(12):1373-82, following 1382. PubMed ID: 19048116
[TBL] [Abstract][Full Text] [Related]
3. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
4. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.
Doucette T; Yang Y; Zhang W; Fuller GN; Suki D; Fults DW; Rao G
Int J Cancer; 2011 Nov; 129(9):2093-103. PubMed ID: 21171016
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
[TBL] [Abstract][Full Text] [Related]
7. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV
Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486
[TBL] [Abstract][Full Text] [Related]
8. PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
Costa PM; Cardoso AL; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
Hum Mol Genet; 2012 Dec; 21(23):5118-30. PubMed ID: 22922228
[TBL] [Abstract][Full Text] [Related]
9. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
10. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
11. miR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.
Li WQ; Yu HY; Zhong NZ; Hou LJ; Li YM; He J; Liu HM; Xia CY; Lu YC
Int J Oncol; 2015 Apr; 46(4):1601-8. PubMed ID: 25626081
[TBL] [Abstract][Full Text] [Related]
12. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
[TBL] [Abstract][Full Text] [Related]
15. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
[TBL] [Abstract][Full Text] [Related]
17. PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors.
Appolloni I; Calzolari F; Tutucci E; Caviglia S; Terrile M; Corte G; Malatesta P
Int J Cancer; 2009 May; 124(10):2251-9. PubMed ID: 19165863
[TBL] [Abstract][Full Text] [Related]
18. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
19. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
[TBL] [Abstract][Full Text] [Related]
20. ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.
Qi L; Wang ZY; Shao XR; Li M; Chen SN; Liu XQ; Yan S; Zhang B; Zhang XD; Li X; Zhao W; Pan JA; Zhao B; Zhang XD
Oncogene; 2020 Sep; 39(37):5964-5978. PubMed ID: 32753650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]